Craig W Lindsley Selected Research

N- (3- oxo- 3- (4- (pyridin- 4- yl)piperazin- 1- yl)propyl)benzo(c)(1,2,5)thiadiazole- 4- sulfonamide

3/2012	Roles of the M1 muscarinic acetylcholine receptor subtype in the regulation of basal ganglia function and implications for the treatment of Parkinson's disease.
8/2009	A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Craig W Lindsley Research Topics

Disease

60	Schizophrenia (Dementia Praecox) 01/2022 - 11/2004
29	Neoplasms (Cancer) 01/2020 - 01/2005
25	Parkinson Disease (Parkinson's Disease) 08/2021 - 07/2005
20	Alzheimer Disease (Alzheimer's Disease) 12/2020 - 10/2008
12	Catalepsy 01/2021 - 10/2008
6	Seizures (Absence Seizure) 01/2019 - 10/2008
5	Neurodevelopmental Disorders 01/2022 - 01/2017
5	Substance-Related Disorders (Drug Abuse) 01/2021 - 01/2013
5	Infections 12/2018 - 09/2014
5	Neurobehavioral Manifestations 01/2018 - 01/2006
4	Rett Syndrome (Rett's Disorder) 01/2022 - 01/2017
4	Central Nervous System Diseases (CNS Diseases) 08/2021 - 08/2010
4	Obesity 10/2019 - 08/2010
4	Pain (Aches) 05/2019 - 07/2005
4	Psychotic Disorders (Schizoaffective Disorder) 10/2018 - 06/2014
4	Autistic Disorder (Autism) 01/2018 - 09/2012
4	Dyskinesias (Dyskinesia) 01/2016 - 08/2015
4	Fragile X Syndrome (Martin Bell Syndrome) 01/2016 - 09/2012
3	Hypertension (High Blood Pressure) 01/2022 - 01/2013
3	Retinoblastoma (Glioblastoma, Retinal) 01/2022 - 01/2018
3	Cognitive Dysfunction 01/2021 - 05/2013
3	Alcoholism (Alcohol Abuse) 12/2020 - 07/2019
3	Epilepsy (Aura) 01/2020 - 01/2013
3	Brain Diseases (Brain Disorder) 01/2018 - 01/2012
3	Neoplasm Metastasis (Metastasis) 01/2017 - 09/2010
3	Breast Neoplasms (Breast Cancer) 02/2011 - 05/2009
2	Memory Disorders (Memory Loss) 01/2022 - 09/2009
2	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 01/2019
2	Dystonia (Limb Dystonia) 08/2021 - 08/2009
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2020 - 05/2017
2	Anhedonia 01/2020 - 01/2019
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2019 - 03/2015
2	Chagas Disease (American Trypanosomiasis) 12/2018 - 12/2018
2	Mental Disorders (Mental Disorder) 01/2018 - 08/2010
2	Carcinoma (Carcinomatosis) 11/2017 - 01/2017
2	Dementia (Dementias) 01/2017 - 01/2013
2	Cocaine-Related Disorders (Cocaine Addiction) 03/2016 - 08/2013
2	Bipolar Disorder (Manic Depressive Psychosis) 11/2015 - 01/2015
2	Type 2 Diabetes Mellitus (MODY) 11/2015 - 07/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2015 - 12/2013
2	Leukemia 07/2015 - 02/2014
2	Human Influenza (Influenza) 12/2014 - 09/2014
2	Carcinogenesis 10/2014 - 02/2011
2	Glioblastoma (Glioblastoma Multiforme) 01/2014 - 03/2013

Drug/Important Bio-Agent (IBA)

28	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2022 - 10/2008
20	Pharmaceutical PreparationsIBA 01/2022 - 11/2005
20	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2021 - 07/2005
11	Haloperidol (Haldol)FDA LinkGeneric 01/2021 - 11/2008
10	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 01/2006
9	Cholinergic Agents (Cholinergics)IBA 01/2022 - 05/2010
9	Glutamic Acid (Glutamate)FDA Link 01/2019 - 01/2006
7	Phospholipase DIBA 05/2017 - 02/2009
7	N-Methylaspartate (NMDA)IBA 01/2017 - 11/2004
6	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 11/2004
6	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2007
6	metabotropic glutamate receptor 4IBA 01/2016 - 01/2009
6	1-dodecylpyridoxal (PLD)IBA 05/2015 - 09/2010
5	Metabotropic Glutamate 5 ReceptorIBA 03/2016 - 10/2013
5	Levodopa (L Dopa)FDA LinkGeneric 01/2016 - 02/2012
4	Muscarinic M4 ReceptorIBA 12/2020 - 11/2015
4	Phosphotransferases (Kinase)IBA 01/2020 - 12/2005
4	EnzymesIBA 12/2018 - 02/2015
4	Dopamine (Intropin)FDA LinkGeneric 01/2018 - 01/2006
4	LigandsIBA 11/2017 - 01/2015
4	Cadherins (E-Cadherin)IBA 01/2017 - 05/2011
4	Glutamate Receptors (Glutamate Receptor)IBA 12/2016 - 05/2012
3	Dizocilpine Maleate (Dizocilpine)IBA 01/2022 - 03/2016
3	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 01/2018
3	gamma-Aminobutyric Acid (GABA)IBA 01/2022 - 08/2015
3	Retinaldehyde (Retinal)IBA 01/2022 - 01/2018
3	metabotropic glutamate receptor 7IBA 01/2021 - 01/2018
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021 - 01/2013
3	Clozapine (Clozaril)FDA LinkGeneric 01/2018 - 07/2013
3	Phosphatidic Acids (Phosphatidic Acid)IBA 05/2015 - 02/2011
2	PotassiumIBA 01/2022 - 01/2011
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022 - 11/2021
2	Neurotransmitter Agents (Neurotransmitter)IBA 08/2021 - 03/2015
2	Opioid Analgesics (Opioids)IBA 01/2021 - 01/2019
2	Acetylcholine (Acetylcholine Chloride)FDA Link 12/2020 - 01/2020
2	Baclofen FDA LinkGeneric 01/2020 - 01/2019
2	Muscarinic M1 ReceptorIBA 01/2019 - 10/2017
2	SterolsIBA 12/2018 - 12/2018
2	Biological ProductsIBA 12/2018 - 09/2010
2	benzocycloheptapyridineIBA 01/2018 - 01/2013
2	metabotropic glutamate receptor 2IBA 01/2018 - 01/2009
2	Serotonin (5 Hydroxytryptamine)IBA 01/2018 - 03/2015
2	Caspase 3 (Caspase-3)IBA 01/2018 - 02/2005
2	RNA (Ribonucleic Acid)IBA 01/2018 - 09/2009
2	IsoxazolesIBA 11/2017 - 10/2017
2	IsoenzymesIBA 05/2017 - 02/2005
2	Antiviral Agents (Antivirals)IBA 05/2017 - 12/2014
2	LipidsIBA 05/2017 - 05/2015
2	xanomelineIBA 01/2017 - 05/2010
2	N-(3-chlorophenyl)picolinamideIBA 08/2015 - 02/2012
2	Amphetamine (Amfetamine)FDA LinkGeneric 03/2015 - 07/2014
2	metabotropic glutamate receptor 3 (mGluR3)IBA 01/2015 - 01/2009
2	Peptides (Polypeptides)IBA 01/2015 - 07/2014
2	Exenatide (Byetta)FDA Link 12/2014 - 07/2014

Therapy/Procedure

22	Therapeutics 08/2021 - 11/2005
5	Drug Therapy (Chemotherapy) 11/2021 - 01/2005